OGEN News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$2.0M

Volume

32.55K

Next Earnings

November 6th

Chart Financials Earnings News About Insider Filings

Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion TrialOragenics, Inc. has submitted a clinical trial protocol for regulatory review to the Health and Disability Ethics Committee in New Zealand for its Phase II trial evaluating ONP-002, a proprietary neurosteroid therapy, for the treatment of mild traumatic brain injury or concussion.GlobeNewswire Inc. · Apr 9, 2025

Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing StandardsOragenics provides an update on its drug candidate ONP-002 for treating concussion, including positive developments in stability, formulation, and clinical trial preparation. However, the company also discloses non-compliance with NYSE American listing standards.GlobeNewswire Inc. · Aug 16, 2024

Oragenics delays 2023 Annual Meeting - Investing.comOragenics, a biopharmaceutical company, has postponed its 2023 Annual Meeting of Shareholders, previously scheduled for August 26, 2024. The company stated that a new meeting date will be set and communicated in the future.Investing.com · Jul 22, 2024

Oragenics Develops Automated Intranasal Device for Treating Concussed PatientsThe device is intended for initial treatment in the acute setting The device is intended for initial treatment in the acute settingGlobeNewswire Inc. · Jun 27, 2024

Oragenics, Inc. Announces Closing of Public OfferingSARASOTA, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced the closing of its public offering of 1,100,000 shares of its common stock at an offering price of $1.00 per share.GlobeNewswire Inc. · Jun 26, 2024

Oragenics, Inc. Announces Pricing of Public OfferingSARASOTA, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has entered into a placement agency agreement for the purchase and sale of 1,100,000 shares of its common stock (or pre-funded warrants in lieu thereof) at an offering price of $1.00 per share. The closing of the public offering is expected to occur on or about June 26, 2024, subject to the satisfaction of customary closing conditions.GlobeNewswire Inc. · Jun 25, 2024

Oragenics, Inc. Announces Proposed Public OfferingSARASOTA, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE: OGEN) (“Oragenics” or the “Company”), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants in lieu thereof). All of the securities to be sold in the offering are to be offered by Oragenics. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.GlobeNewswire Inc. · Jun 24, 2024

S&P 500 Edges Lower; ADT Posts Upbeat EarningsU.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The S&P 500 also fell, dropping, 0.18% to 5,068.92. Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Real estate shares rose by 1.4% on Wednesday. In trading on Wednesday, communication services shares fell by 0.8%. Top Headline ADT Inc. (NYSE: ADT) reported better-than-expected earnings for its fourth quarter on Wednesday. ADT posted fourth-quarter fiscal 2023 sales decline of 7.2% year-on-year to $1.22 billion, missing the consensus of $1.44 billion. Adjusted EPS was 25 cents, beating the consensus of 4 cents. ADT expects CSB segment revenue of 4.8 billion-$5.0 billion. The company expects adjusted EPS of $0.60 – $0.70, against consensus of $0.50. Equities Trading UP Vivani Medical, Inc. (NASDAQ: VANI) shares shot up 274% to $3.78 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139. Shares of Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) got a boost, surging 159% to $2.1917. ...Benzinga · Feb 28, 2024

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. Bumble reported quarterly losses of 19 cents per share which missed the analyst consensus estimate of 12 cents per share. The company reported quarterly sales of $273.64 million which missed the analyst consensus estimate of $275.29 million. Bumble shares dipped 11.6% to $11.65 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Vivani Medical, Inc. (NASDAQ: VANI) shares jumped 289% to $3.93 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) climbed 190% to $2.4598. Adial Pharmaceuticals secured new US patent covering lead product for alcohol use disorder. vTv Therapeutics Inc. (NASDAQ: VTVT) gained 112% to $17.65 after the company announced a $51 million private placement from healthcare-focused institutional investors and the JDRF T1D Fund. Bit Brother Limited (NASDAQ: BETS) shares rose 63.7% to $4.0750. Beyond Meat, Inc. (NASDAQ: BYND) climbed 45% to $10.90 as the company reported stronger-than-expected sales for its fourth quarter. Incannex Healthcare Inc. (NASDAQ: IXHL) gained 43.6% to $6.06 after the company announced its Psi-GAD1 trial met its primary endpoint. Bandwidth Inc. (NASDAQ: BAND) surged 43.3% to $17.41 after the company reported better-than-expected fourth quarter financial results and issued FY24 revenue guidance above estimates. Imunon, Inc. (NASDAQ: IMNN) climbed 38% to $0.98. Applied Therapeutics, Inc. (NASDAQ: APLT) surged 36% to $7.59 after the company announced FDA acceptance and priority review of the NDA for govorestat for the treatment of Classic Galactosemia. The company also announced a $100 million private placement. Movella Holdings Inc. (NASDAQ: MVLA) gained 33.5% to $0.33. LifeStance Health Group, Inc. (NASDAQ: LFST) gained 31.5% to $8.81 following strong quarterly sales. AirNet Technology Inc. (NASDAQ: ANTE) rose 31.3% to $1.05. AirNet announced changes in senior management team. Polestar Automotive Holding UK PLC (NASDAQ: PSNY) rose 29.9% to $1.9350. Polestar secured $1 billion external funding. Editas Medicine, Inc. (NASDAQ: EDIT) gained 27.7% to $11.31 after the company reported better-than-expected fourth-quarter financial results. TG Therapeutics, ...Benzinga · Feb 28, 2024

Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M BarrelsU.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded down 0.19% to 38,899.92 while the NASDAQ fell 0.31% to 15,985.25. The S&P 500 also fell, dropping, 0.11% to 5,072.67. Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Real estate shares rose by 1.1% on Wednesday. In trading on Wednesday, health care shares fell by 0.8%. Top Headline U.S. crude oil inventories increased by 4.199 million barrels in the week ending Feb. 23, versus market estimates of a 2.743 million gain, the EIA said. Equities Trading UP Vivani Medical, Inc. (NASDAQ: VANI) shares shot up 301% to $4.05 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139. Shares of Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) got a boost, surging 164% to $2.2350. Adial Pharmaceuticals secured new US patent covering lead product for alcohol use disorder. vTv Therapeutics Inc. (NASDAQ: VTVT) shares were also up, gaining 136% to $19.61 after the ...Benzinga · Feb 28, 2024

OGENOragenics Inc.

OGEN

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any OGEN yet.

Related Tickers

Earnings

Mkt Cap

$2.0M

Volume

32.55K

Next Earnings

November 6th